HSD47 Treatment Response, Healthcare Resource Use, and Economic Outcomes Associated With Tumor Necrosis Factor Inhibitor Cycling Versus Switching to an Advanced Therapy With Different Mechanism of Action in Rheumatoid Arthritis
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.1270
https://www.valueinhealthjournal.com/article/S1098-3015(24)01385-8/fulltext
Section Title :
Section Order :
10668
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01385-8&doi=10.1016/j.jval.2024.03.1270